The National Community Pharmacists Association and the National Association of Chain Drug Stores has issued a joint statement in which they state that the FTC asked the two pharmacy groups for ways to revise the Medco-Express Scripts deal. The groups, who have been opposed to the acquisition, have responded with suggestions for possible remedies. However, the joint statement also affirms continued criticism of the transaction, and that their preference is for the FTC not to settle, but fight the merger in court.
Featured News
EU Probes Meta Over Potential AI Restrictions on WhatsApp
Dec 7, 2025 by
CPI
Netflix’s $72bn Purchase Bid Triggers Concerns Over Consumer Choice
Dec 7, 2025 by
CPI
Judge Formalizes Limits on Google’s Deals With Apple and AI Expansion
Dec 7, 2025 by
CPI
Florida Governor DeSantis Pitches AI Bill of Rights for Residents and Local Governments
Dec 7, 2025 by
CPI
CFTC Gives Formal Blessing to Spot Trading of Crypto on Registered Exchange
Dec 7, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Intellectual Property
Nov 19, 2025 by
CPI
Dealing in Intellectual Property: IP Justifications and Defenses in Digital Markets Cases
Nov 19, 2025 by
Jennifer Dixton
The Evolving Role of Innovation Theories of Harm in the Antitrust Analysis of Life Science Mergers
Nov 19, 2025 by
Michelle Yost Hale, Matthew D. McDonald & Merrill Stovroff
Who Can Fix It? Antitrust, IP Rights, and the Right to Repair
Nov 19, 2025 by
Rosa M. Morales
Copyright, Antitrust, and the Politics of Generative AI
Nov 19, 2025 by
Daryl Lim